Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 to 69 years old may be considered for inclusion.
- All participants will need to sign a consent form agreeing to take part in the study.
- Because this is an observational study (meaning researchers observe rather than intervene), people who are pregnant or breastfeeding may also be considered for inclusion.
- For people with Crohn's disease (a type of bowel condition): participants need to have already been classified into one of three disease stages — B1 (more inflammatory, less structural change), B2 (structural narrowing but no penetration), or B3 (structural narrowing and penetration) — based on prior scans such as CT, MRI, or ultrasound done as part of their standard medical care.
- For people without inflammatory bowel disease (IBD): people scheduled to have surgery for a non-IBD bowel condition, such as diverticulitis, as part of their standard medical care may be considered for inclusion.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with Crohn's disease who have not previously been classified into the B1, B2, or B3 disease stages would not be eligible.
- People under 18 years old or over 70 years old would not be eligible (this applies to both Crohn's disease and non-IBD participants).
- People who have not signed the required consent form would not be eligible (this applies to both Crohn's disease and non-IBD participants).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0226437864
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
To perform flow cytometry, RNAseq, metatranscriptomics, transcriptomics and lipidomics on CD and non-IBD cells
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.